How Is The Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Performance Outlook For The Coming Months?
Mereo Biopharma Group Plc ADR (NASDAQ:MREO) has a beta value of 0.91 and has seen 1.63 million shares traded in the last trading session. The
Mereo Biopharma Group Plc ADR (NASDAQ:MREO) has a beta value of 0.91 and has seen 1.63 million shares traded in the last trading session. The
During the last session, Mereo Biopharma Group Plc ADR (NASDAQ:MREO)’s traded shares were 0.62 million, with the beta value of the company hitting 0.91. At
Mereo Biopharma Group Plc ADR (NASDAQ:MREO)’s traded shares stood at 0.78 million during the last session, with the company’s beta value hitting 0.91. At the
In last trading session, Mereo Biopharma Group Plc ADR (NASDAQ:MREO) saw 0.49 million shares changing hands with its beta currently measuring 0.95. Company’s recent per
In today’s recent session, 0.77 million shares of the Mereo Biopharma Group Plc ADR (NASDAQ:MREO) have been traded, and its beta is 0.98. Most recently
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.